Risperidone Induced Xerosis and Tachycardia in Schizophrenia Patients: A Case Report

DOI

10.2991/ahsr.k.210115.069How to use a DOI?

Keywords

risperidone, schizophrenia, side-effects, tachycardia, xerosis

Abstract

Background: Risperidone is one of the atypical antipsychotics usually used in schizophrenia therapy. Like most antipsychotics, risperidone has several side effects. Xerosis and tachicardy are rare side effects of Risperidone with incidence <1%. However unfortunately, the numbers of case reports about risperidone’s side effects are very limited, especially in Indonesia. The case report aims to inform the health professionals about the side effect of risperidone in Schizophrenia patienst in Indonesia. Case presentation: A 54-year-old woman was hospitalized with a diagnosis of schizophrenia. The patient received risperidone 2mg, clozapine 25mg, 1/2 ampule haloperidol injection, cetirizine 10mg, methylprednisolone 4mg, amlodipine 5mg. On the following day, the patient experienced itching, hardening of the facial skin and tachycardia (pulse 124). The Naranjo score for riperidone was 6 (probably). After the incident, the physicians stopped the risperidone. The patient was then prescribed a facial lotion to treat her dry and peeling facial skin. After discontinuing the risperidone, the patient’s facial skin condition improved, and the pulse was normal. Conclusion: Risperidone is known to have side effects of xerosis and tachycardia in these patients, so healthcare professionals should monitor the use of risperidone and other antipsychotics to anticipate potential side effects.

Copyright

© 2021, the Authors. Published by Atlantis Press.

Open Access

This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

Download article (PDF)

TY  - CONF
AU  - Bangunawati Rahajeng
AU  - Pinasti Utami
AU  - Astrit Ikafitriani
PY  - 2021
DA  - 2021/01/16
TI  - Risperidone Induced Xerosis and Tachycardia in Schizophrenia Patients: A Case Report
BT  - Proceedings of the 4th International Conference on Sustainable Innovation 2020–Health Science and Nursing (ICoSIHSN 2020)
PB  - Atlantis Press
SP  - 327
EP  - 331
SN  - 2468-5739
UR  - https://doi.org/10.2991/ahsr.k.210115.069
DO  - 10.2991/ahsr.k.210115.069
ID  - Rahajeng2021
ER  -